Chalet, François-Xavier http://orcid.org/0000-0002-2178-8920
Bujaroska, Teodora
Germeni, Evi http://orcid.org/0000-0001-5576-8816
Ghandri, Nizar
Maddalena, Emilio T.
Modi, Kushal
Olopoenia, Abisola
Thompson, Jeffrey
Togninalli, Matteo
Briggs, Andrew H. http://orcid.org/0000-0002-0777-1997
Funding for this research was provided by:
Idorsia Pharmaceuticals
Article History
Accepted: 12 January 2023
First Online: 26 January 2023
Change Date: 11 February 2023
Change Type: Update
Change Details: The name of one author has been corrected in the ESM.
Declarations
:
: Idorsia Pharmaceuticals Ltd funded this research study, including access to the NHWS data and the analytical work by Visium.
: Teodora Bujaroska, Nizar Ghandri, Emilio Tanowe Maddalena, and Matteo Togninalli are employees of Visium Ltd, which received funding from Idorsia Pharmaceuticals Ltd to conduct this study. Kushal Modi, Abisola Olopoenia and Jeffrey Thompson are employees of Cerner Enviza, which received funding from Idorsia Pharmaceuticals Ltd to conduct this study. Andrew Briggs and Evi Germeni were contracted through Avalon Health Economics LLC, which received fees from Idorsia Pharmaceuticals Ltd. François-Xavier Chalet is an employee of, and holds shares in, Idorsia Pharmaceuticals Ltd.
: The protocol and questionnaire for the NHWS were reviewed and granted exemption status by Pearl Institutional Review Board (Indianapolis, IN, USA; 19-KANT-204).
: The NHWS is a commercial dataset. Access to the dataset used in this present paper must be requested to Cerner Enviza via the following link: ExternalRef removed. Data access conditions will be detailed by the responsible team.
: All respondents have provided informed consent prior to their participation.
: All respondents have provided informed consent prior to their participation, with the potential for publication.
: R scripts to reproduce the analyses are available in the ESM. Code needs to be run against the original dataset.
: Conceptualisation: F-XC, AB. Methodology: F-XC, JT, MT, AB. Formal analysis and investigation: TB, NG, ETM, KM. Writing—original draft preparation: F-XC, NG, ETM, KM, JT, MT, AB. Writing—review and editing: F-XC, TB, EG, AO, JT, MT, AB. Approval of the final version: All authors.